Frontiers in Neuroscience · 2019 · 31 citations · 56 references
MedicineNeurologyPsychologyDementiaMemoryNeuropsychologyAlzheimer DiseaseCognitive AssessmentCognitive DeclineCognitive ImpairmentNeurocognitive AssessmentNeuropsychological AssessmentCognitive Impairment EvaluationCognitive Impairment Risk AssessmentConversion From Subjective Cognitive Decline To DementiaImmediate Verbal RecallNeurocognitive DeclineNeuropsychological DeclineReceiver Operating Characteristic AnalysisVerbal Learning Tests
Background: Since subjective cognitive decline (SCD) was standardized in 2014, there have been few studies reporting the risk factors and neuropsychological assessment characteristics of SCD (plus) in memory clinic. Objective: To characterize SCD (plus) by comparing it with normal control (NC), amnesic mild cognitive impairment (aMCI), and Alzheimer Disease (AD) regarding their demographics, lifestyle, family history of dementia, multimorbidity and the neuropsychological assessments. Methods: A total of 135 participants were recruited, including 23 NC, 30 SCD (plus), 45 aMCI and 37 AD. Descriptive statistics were provided. A logistic regression model was used to analyze the affecting factors of SCD (plus), and finally the Receiver Operating Characteristic (ROC) analysis was applied to distinguish between SCD (plus) and NC. Results: (1) SCD (plus) group was younger than both the aMCI group and AD group. It consisted of more participants with mental work and higher body mass index (BMI) than the AD group. (2) Scores of Auditory Verbal Learning Test - Immediate recall (AVLT-IR) and AVLT-Long delayed recall (AVLT-LR) decreased in the following order: NC→SCD (plus)→aMCI→AD. (3) The Area Under Curve (AUC) for discriminating SCD (plus) and NC group was from 0.673 to 0.838. Conclusions: Ageing is an important risk factor of both NC progressing to SCD (plus), and SCD (plus) progressing to aMCI or AD. In addition to ageing, lower education level and lower BMI were significantly associated with greater odds of SCD (plus) progressing to aMCI or AD patients, whereas mental work was a protective factor of SCD (plus) progressing to AD. Finally, AVLT is a sensitive indicator of the cognitive decline and impairment in SCD (plus) in relative to normal controls.
56
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
The Clinical Dementia Rating (CDR)
John C. Morris · Neurology · 1993 · 10K citations
Medicine, Neurology, Psychiatry +12
Hearing Loss and Cognitive Decline in Older Adults
JAMA Internal Medicine · 2013 · 3.8K citations
2013 Alzheimer's disease facts and figures
William Thies, Laura Bleiler · Alzheimer s & Dementia · 2013 · 3.3K citations
Cerebral Blood Flow in Dementia
Vladimir Hachinski, L. D. Iliff, E. Zilhka et al. · Archives of Neurology · 1975 · 3.2K citations
Medicine, Neurology, Neuroscience +14